← Open Payments lookup

NICHOLAS DRESSEL: Open Payments

NPI 1285110494 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$873 in 54 payments from 17 companies in 2025. Trend: 2023 $1,727 · 2024 $1,675 · 2025 $873

Food & beverage: $873
CompanyPaymentsAmount
Lilly USA, LLC11$240
Amgen Inc.14$137
Novo Nordisk Inc5$81
GlaxoSmithKline, LLC.4$76
SANOFI PASTEUR INC.2$57
Gilead Sciences, Inc.2$48
PFIZER INC.2$35
AstraZeneca Pharmaceuticals LP2$29
Renalytix AI, Inc.2$29
Phathom Pharmaceuticals, Inc.2$22

Products named: ZEPBOUND, MOUNJARO, EVENITY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, OTEZLA, Ozempic, TRELEGY ELLIPTA, Wegovy.

Industry payments across TX — which companies pay providers there.